PORTLAND, Ore., Sept. 27 /PRNewswire/ --
Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of
needle-free drug delivery systems, today announced that it will host a
conference call and webcast to update shareholders, investors and interested
parties on its business opportunities. The company abbreviated its planned
presentation at its annual shareholders meeting on September 13, 2001 due to
the events in New York and Washington D.C.
WHEN: 11:00 a.m. EDT Wednesday October 3, 2001
WHO: Jim O'Shea, chairman, president and chief executive
officer
DIAL IN: 800-360-9865, and request Bioject
WEBCAST: http://www.bioject.com
REPLAY: On the Internet at http://www.bioject.com
-- Investors/presentations
Bioject Medical Technologies Inc., based in Portland, Oregon, is an
innovative developer and manufacturer of needle-free drug delivery systems.
Needle-free injection works by forcing medication at high speed through a tiny
orifice held against the skin. This creates a fine stream of high-pressure
fluid penetrating the skin and depositing medication in the tissue beneath.
The company is focused on developing mutually beneficial agreements with
leading pharmaceutical and biotechnology companies. Bioject's partners now
include Amgen and Serono.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors
which may cause the actual results, performance or achievements of the
company, or industry results, to be materially different from any future
results, performance, or achievements expressed or implied by such
forward-looking statements. Readers of this press release are referred to the
company's filings with the Securities and Exchange Commission, including the
company's Annual Report on Form 10-K for the year ended March 31, 2001 for
further discussions of factors which could affect future results.
Forward-looking statements are based on the estimates and opinions of
management on the date the statements are made. The company assumes no
obligation to update forward-looking statements if conditions or management's
estimates or opinions should change.
More information can be found at Bioject's home page at:
http://www.bioject.com/ .
SOURCE Bioject Medical Technologies Inc.
 back to top
Related links:
http://www.bioject.com
Company News On-Call:
http://www.prnewswire.com/gh/cnoc/comp/101750.html
CONTACT:
Jim O'Shea, Chairman, President & CEO of
Bioject Medical Technologies Inc., +1-503-639-7221, ext. 565; or
investors, Jim Flanagan of IR Strategic Advisors,
+1-781-863-1333, or jflanagan@iradvisors.com, for Bioject Medical
Technologies, Inc.
|
